Cansinobio announced on April 20, 2023, that there will be a change in senior management. Current CEO Xuefeng YU will step down on November 25, 2024. This change may have an impact on the company's future development and strategic direction. Under Xuefeng YU's leadership, the company has achieved significant accomplishments in recent years. In the future, the company will seek a suitable successor to ensure the business's continued growth and stability. Investors should closely monitor future management changes in the company and their impact on the business. Cansinobio emphasizes that it will continue to focus on innovation and market expansion to maintain its competitive advantage in the biopharmaceutical field. The company plans to strengthen R&D investment in the coming years and explore new market opportunities.

Cansinobio announced on April 20, 2023, that there will be a change in senior management. Current CEO Xuefeng YU will step down on November 25, 2024. This change may have an impact on the company's future development and strategic direction. Under Xuefeng YU's leadership, the company has achieved significant accomplishments in recent years. In the future, the company will seek a suitable successor to ensure the business's continued growth and stability. Investors should closely monitor future management changes in the company and their impact on the business. Cansinobio emphasizes that it will continue to focus on innovation and market expansion to maintain its competitive advantage in the biopharmaceutical field. The company plans to strengthen R&D investment in the coming years and explore new market opportunities.